CannMed 2017 | 2017 Presentations and Posters
1220
page-template,page-template-full_width,page-template-full_width-php,page,page-id-1220,ajax_fade,page_not_loaded,,side_area_uncovered_from_content,qode-theme-ver-10.0,wpb-js-composer js-comp-ver-5.1.1,vc_responsive

CannMed 2017 Oral Presentations

 
It’s Not Easy Being Green: Assessing the Impact of Medical Marijuana on Cognition, Mood, Brain Function and Related Measures
Staci Gruber Ph.D.

 
Automation Solutions for High Throughput Pesticides Analysis in Cannabis Labs
Ryan Ravenelle Ph.D.

 
Cannabis Contaminants: Practical Considerations VS. Regulatory Requirements
Christopher Hudalla Ph.D.

 
The Endocannabinoid System: A Fifty-Year Trip
Prof. Raphael Mechoulam

 
The Endocannabinoid System – A Source for Drug Discovery
Alexandros Makriyannis Ph.D.

 
Use of CB2 Receptor Inverse Agonists in the Treatment of Traumatic Brain Injury
Anton Reiner Ph.D.

 
Hydrogenated Cannabis Oil
Mark Scialdone Ph.D.

 
How Patients Benefit from Medical Cannabis
Bonni Goldstein MD

 
A Clinician’s Approach to Managing Uncertainty in Medically Refractory Patients
John Gaitanis MD

 
Cannabis Therapeutic Use in the Elderly
Deborah Malka MD

 
Open Source CNS (Cannabis Nomenclature System) and the Decentralization of Cannabis Genomics
Kevin McKernan

 
Elucidating Cannabinoid Biosynthesis Using Trichome Targeted Genomics
Jonathan Page Ph.D.
Download Slides

 
Cannabis Used in Research Does Not Reflect Legal Markets
Nolan Kane Ph.D.

 
The Role of Cannabidiol in the Treatment of Refractory Pediatric Epilepsy
Elizabeth Thiele MD

 
Cannabidiol (Epidiolex) in Dravet and Lennox-Gastaut Syndromes: Preliminary Clinical Trial Results
Orrin Devinsky MD

 
Toward Precision Medicine for Cannabidiol Treatment in Epilepsy, and the Impact of Rare Variation in Endocannabinoid System Genes
Douglas R. Smith Ph.D.

 
Potential Clinical Benefits of CBD-Enriched Extracts Over Purified CBD in Treatment-Resistant Epilepsy
Fabricio Pamplona Ph.D.

 
Israel, Leading a Process: From Illegal Substance to Potent Medication
Michael Dor MD
Download Slides

 
A Personal Story
Amir Golan

 
Is Cannabis a Solution to the Opioid Epidemic?
Dustin Sulak DO

 
Assertations v. Evidence, Kindly Check Your Assertions at the Door
Jeffrey Hergenrather MD

 
Case Presentations of Cancer Patients Treated with Low Dose Cannabis Oil Alone or in Combination with Conventional Therapy
Debra Kimless MD

 
Matching an Effective Cannabis Strain Extract for a Specific Subtype of Cancer
David Meiri Ph.D.
Download Slides

 
Comparison of the Anti-Tumor Efficacy of a Whole-Plant Extract vs. Pure THC in Preclinical Models of HER2-Positive Breast Cancer
Mara Gordon

 
Cannabinoids as Antitumor Agents: Moving Toward the Clinic
Sean McAllister

 
How to Legally Recommend Cannabis to Your Patients
Valerio Romano, Attorney
Michael D. Cutler, Attorney
Bonni Goldstein, MD

 
Cannabinoids as Medicine: Pain and CNS Injury
Sara Jane Ward Ph.D.
Download Slides

 
Impact of Standardized Cannabis Therapy in Chronic Noncancer Pain with or without Opiate Use
Kent Crowley Pharm.D.

 
Cannabis for Pain Management and Opioid Use Reduction 
Jordan Tishler MD

 
Panel Discussion: Cannabis as Medicine in Professional Sports
David Nathan MD
Perry Soloman MD
Eben Britton, Former NFL Guard and Tackle
Nate Jackson, Former NFL Wide Receiver
Lance Johnstone, Former NFL Defensive End
Ricky Williams, Former NFL Running Back
Jim McAlpine, Founder 420 Games

A Mother’s Story: What is the Drug War, Really?
Lyn Ulbricht

CannMed 2017 Poster Presentations

Life is a Highway: Assessing the Residual Impact of Heavy Recreational Marijuana Use Without Acute Intoxication on Driving
Mary Kathryn Dahlgren
Navigating Patients through the Maze of Information and Mis-Information about Medicinal Cannabis
PENNY DAUGHERTY, RN, OCN.
Dr. Uma’s Total Health Care THC
UMA V A DHANABALAN, MD, MPH, FAAFP
Vaping’s Past as Medicinal Cannabis’ Prologue: How the FDA’s Expectations of Respiratory Drug Delivery Create Parallel Challenges for the Vaping and Medicinal Cannabis Industries
MICHAEL HUFFORD, PH.D
Snap, Crackle, and Pot: Exploring the Use of Marijuana Concentrates and Dabbing
ASHLEY MARIE LAMBROS
In Search of Efficacy:
A self-reported patient study identifying eective THC:CBD ratios for sleep, pain and arousal based on dose-controlled delivery of vaporized cannabis oil

Samantha Miller
Cannabinoids-based Medicine as a Pivotal Model for Personalized Integrative Care
ILYA REZNIK, MD
Customized Cannabus Concentrates Optimizing Supercritical CO2 Extraction For Targeted Cannabis Oil Production
Markus Roggen, Ph.D
Understanding Cannabis Data: Analysis to Analytics
SAVINO SGUERA
Delivery of Cannabinoids to the Bloodstream via Inhalation of Dry Powder Aerosols or Sublingual Absorption of Dry Powder Compressed Wafers
D. ROBERT SIEVERS, PH.D
LIA REBITS, PH.D
XUNO GIL DE LA MADRID
Blunting the Pain: The Impact of Three Months of Medical Marijuana Treatment on Pain, Quality of Life, and Cognition in Patients with Chronic Pain
ROSEMARY T. SMITH
Terpenes and Terpenoids of Cannabis: A Medical Review
MARCO TROIANI
Acute Marijuana Use: Functional Findings of Retinal Ganglion Cell Impairment
DENISE A. VALENTI, OD
Beyond Schedule I or II: On the Development of Cannabinoid-Based Drugs Appropriate for Less Restrictive Scheduling under the Controlled Substance Act
DANIEL WANG